CAS introduces world's first Stereoselective Labeling capability in CAS SciFinder? Retrosynthesis Tool

CAS, a division of the American Chemical Society, renowned for its expertise in scientific knowledge management, has unveiled a ground breaking feature in its CAS SciFinder? retrosynthesis tool: stereoselective labeling. This first-of-its-kind capability in scientific technology solutions allows researchers to precisely label stereoselective steps within predictive retrosynthesis, marking a new milestone for drug development and chemical synthesis.

With stereoselective labeling, scientists can now design molecules with greater precision—an advancement expected to significantly impact fields like pharmaceuticals, where designing drugs with optimal efficacy and minimized side effects is crucial. By combining this feature with the industry-leading CAS Content Collection? and cutting-edge technology, CAS SciFinder empowers researchers to innovate confidently.

The new stereoselective capability, which includes human-curated, predictive stereochemistry, expands CAS SciFinder’s coverage of unique stereoselective transformations by 30%. It also offers new filtering options, allowing scientists to refine their search based on stereochemistry, ultimately simplifying complex synthetic planning.

This innovation represents an ongoing commitment by CAS to enhance its scientific information solutions. Known for its extensive, reliable collection of chemical reactions, CAS continues to add new functionalities that help researchers build connections between existing knowledge and emerging discoveries, accelerating the journey from concept to reality.

For further details on the CAS SciFinder retrosynthetic analysis capabilities, visit CAS Retrosynthesis.

Click here to read the original press release.